Step 1: Begin from the toxicity profile of raltegravir, the integrase inhibitor used in HIV therapy. A well known but serious effect is muscle injury that can progress to rhabdomyolysis.
Step 2: Rhabdomyolysis means skeletal muscle cells are breaking apart. Potassium is the dominant cation stored inside cells, so when muscle membranes rupture, potassium floods into the circulation.
Step 3: The net laboratory result of this potassium leak is a high serum potassium level, that is hyperkalemia, which can be dangerous for cardiac rhythm.
Step 4: The remaining options point the wrong way. A drop in potassium or a rise in calcium would not arise from muscle destruction, and any calcium change in rhabdomyolysis is typically a fall, not a rise. So the answer derived through the rhabdomyolysis pathway is hyperkalemia.
\[\boxed{\text{Hyperkalemia}}\]